|
1
|
Shah JP, Karnell LH, Hoffman HT, et al:
Patterns of care for cancer of the larynx in the United States.
Arch Otolaryngol Head Neck Surg. 123:475–483. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar
|
|
3
|
Zhao XD, Zhang W, Liang HJ and Ji WY:
Overexpression of miR-155 promotes proliferation and invasion of
human laryngeal squamous cell carcinoma via targeting SOCS1 and
STAT3. PLoS One. 8:e563952013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pevny LH and Lovell-Badge R: Sox
genes find their feet. Curr Opin Genet Dev. 7:338–344. 1997.
View Article : Google Scholar
|
|
5
|
Masui S, Nakatake Y, Toyooka Y, et al:
Pluripotency governed by Sox2 via regulation of
Oct3/4 expression in mouse embryonic stem cells. Nat Cell
Biol. 9:625–635. 2007.
|
|
6
|
Fong H, Hohenstein KA and Donovan PJ:
Regulation of self-renewal and pluripotency by Sox2 in human
embryonic stem cells. Stem Cells. 26:1931–1938. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takahashi K, Tanabe K, Ohnuki M, et al:
Induction of pluripotent stem cells from adult human fibroblasts by
defined factors. Cell. 131:861–872. 2007. View Article : Google Scholar
|
|
8
|
Hussenet T and du Manoir S: SOX2 in
squamous cell carcinoma: amplifying a pleiotropic oncogene along
carcinogenesis. Cell Cycle. 9:1480–1486. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rodriguez-Pinilla SM, Sarrio D,
Moreno-Bueno G, et al: Sox2: a possible driver of the basal-like
phenotype in sporadic breast cancer. Mod Pathol. 20:474–481. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wilbertz T, Wagner P, Petersen K, et al:
SOX2 gene amplification and protein overexpression are
associated with better outcome in squamous cell lung cancer. Mod
Pathol. 24:944–953. 2011. View Article : Google Scholar
|
|
11
|
Gangemi RM, Griffero F, Marubbi D, et al:
SOX2 silencing in glioblastoma tumor-initiating cells causes
stop of proliferation and loss of tumorigenicity. Stem Cells.
27:40–48. 2009. View Article : Google Scholar
|
|
12
|
Lu Y, Futtner C, Rock JR, et al: Evidence
that SOX2 overexpression is oncogenic in the lung. PLoS One.
5:e110222010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tung CL, Hou PH, Kao YL, et al: SOX2
modulates alternative splicing in transitional cell carcinoma.
Biochem Biophys Res Commun. 393:420–425. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bae KM, Su Z, Frye C, et al: Expression of
pluripotent stem cell reprogramming factors by prostate tumor
initiating cells. J Urol. 183:2045–2053. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sanada Y, Yoshida K, Ohara M, Oeda M,
Konishi K and Tsutani Y: Histopathologic evaluation of stepwise
progression of pancreatic carcinoma with immunohistochemical
analysis of gastric epithelial transcription factor SOX2:
comparison of expression patterns between invasive components and
cancerous or nonneoplastic intraductal components. Pancreas.
32:164–170. 2006.
|
|
16
|
Ye F, Li Y, Hu Y, Zhou C, Hu Y and Chen H:
Expression of Sox2 in human ovarian epithelial carcinoma. J Cancer
Res Clin Oncol. 137:131–137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu XL, Xing BC, Han HB, et al: The
properties of tumor-initiating cells from a hepatocellular
carcinoma patient’s primary and recurrent tumor. Carcinogenesis.
31:167–174. 2010.
|
|
18
|
Tang XB, Shen XH, Li L, Zhang YF and Chen
GQ: SOX2 overexpression correlates with poor prognosis in laryngeal
squamous cell carcinoma. Auris Nasus Larynx. 40:481–486. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Adya R, Tan BK, Punn A, Chen J and Randeva
HS: Visfatin induces human endothelial VEGF and MMP-2/9 production
via MAPK and PI3K/Akt signalling pathways: novel insights into
visfatin-induced angiogenesis. Cardiovasc Res. 78:356–365. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stolzenburg S, Rots MG, Beltran AS, et al:
Targeted silencing of the oncogenic transcription factor
SOX2 in breast cancer. Nucleic Acids Res. 40:6725–6740.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Y, Zhao Y, Liu Y, Tian L and Jin D:
Chamaejasmine inactivates Akt to trigger apoptosis in human HEp-2
larynx carcinoma cells. Molecules. 16:8152–8164. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qin FX, Shao HY, Chen XC, et al: Knockdown
of NPM1 by RNA interference inhibits cells proliferation and
induces apoptosis in leukemic cell line. Int J Med Sci. 8:287–294.
2011.
|
|
23
|
Walter MN, Wright KT, Fuller HR, MacNeil S
and Johnson WE: Mesenchymal stem cell-conditioned medium
accelerates skin wound healing: an in vitro study of fibroblast and
keratinocyte scratch assays. Exp Cell Res. 316:1271–1281. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liao W, Liu W, Yuan Q, et al: Silencing of
DLGAP5 by siRNA significantly inhibits the proliferation and
invasion of hepatocellular carcinoma cells. PLoS One. 8:e807892013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ries C, Egea V, Karow M, Kolb H, Jochum M
and Neth P: MMP-2, MT1-MMP, and TIMP-2 are essential for the
invasive capacity of human mesenchymal stem cells: differential
regulation by inflammatory cytokines. Blood. 109:4055–4063. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen X, Liao J, Lu Y, Duan X and Sun W:
Activation of the PI3K/Akt pathway mediates bone morphogenetic
protein 2-induced invasion of pancreatic cancer cells Panc-1.
Pathol Oncol Res. 17:257–261. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ben-Porath I, Thomson MW, Carey VJ, et al:
An embryonic stem cell-like gene expression signature in poorly
differentiated aggressive human tumors. Nat Genet. 40:499–507.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schoenhals M, Kassambara A, De Vos J, Hose
D, Moreaux J and Klein B: Embryonic stem cell markers expression in
cancers. Biochem Biophys Res Commun. 383:157–162. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ji J and Zheng PS: Expression of Sox2 in
human cervical carcinogenesis. Hum Pathol. 41:1438–1447. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Leis O, Eguiara A, Lopez-Arribillaga E, et
al: Sox2 expression in breast tumours and activation in breast
cancer stem cells. Oncogene. 31:1354–1365. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dragutinović VV, Radonjić NV, Petronijević
ND, et al: Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in
preoperative serum as independent prognostic markers in patients
with colorectal cancer. Mol Cell Biochem. 355:173–178.
2011.PubMed/NCBI
|
|
32
|
Ispanovic E and Haas TL: JNK and PI3K
differentially regulate MMP-2 and MT1-MMP mRNA and protein in
response to actin cytoskeleton reorganization in endothelial cells.
Am J Physiol Cell Physiol. 291:C579–C588. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bae IH, Park MJ, Yoon SH, et al: Bcl-w
promotes gastric cancer cell invasion by inducing matrix
metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt,
and Sp1. Cancer Res. 66:4991–4995. 2006. View Article : Google Scholar : PubMed/NCBI
|
